Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe

NCT01389232 is registered in ClinicalTrials.gov with Sofregen Medical, Inc. as lead sponsor.

NCT NCT01389232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01389232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The SeriScaffold® Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery in Europe
Lead sponsor
Sofregen Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2011
Completion date
February 28, 2015
Enrollment
104 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue support and repair